[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365406-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365406-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-interplay-between-cox-2-chemotherapeutic-drugs-and-chemoresistance-in-colon-cancer-original-research","The interplay between COX-2, chemotherapeutic drugs, and chemoresistance in colon cancer - Original research","","Chemoresistance and tumor relapse remain major clinical challenges in colon cancer, with evidence implicating the COX-2/PGE2/EP axis in tumor development and resistance. This study examined COX-2 gene expression in colon cancer patients and assessed how chemotherapy influences COX-2 levels. Tumor and adjacent non-neoplastic tissues were analyzed, and COX-2, TROP2, and DUSP4 were evaluated in fluorouracil and oxaliplatin–treated Caco-2 and SW-620 cells.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-interplay-between-cox-2-chemotherapeutic-drugs-and-chemoresistance-in-colon-cancer-original-research/365406/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-interplay-between-cox-2-chemotherapeutic-drugs-and-chemoresistance-in-colon-cancer-original-research/365406.png","ImageObject",300,407,{"name":42,"@type":43},"Connor ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main aim of this study in colon cancer?","Question",{"text":63,"@type":64},"To assess the relationship between COX-2 gene expression and chemoresistance in colon cancer patients, and to explore how chemotherapy affects COX-2 expression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patient samples collected and analyzed?",{"text":68,"@type":64},"Tumor and adjacent non-neoplastic colon tissue samples were collected from 48 cases and subjected to histopathologic examination, with COX-2 mRNA expression measured after snap-freezing and storage.",{"name":70,"@type":61,"acceptedAnswer":71},"What did in-vitro treatment with 5-fluorouracil and oxaliplatin show?",{"text":72,"@type":64},"Dose-dependent increases in COX-2, TROP2, and DUSP4 mRNA and protein levels were observed in treated Caco-2 and SW-620 cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365406,1790701454,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe interplay between COX-2, chemotherapeutic drugs, and chemoresistance in colon cancer  \nSally M. Shalaby1􀀍, Salma A. Shawky1, Hassan Ashour2 & Walaa Sarhan1  \nChemoresistance and tumor relapse remain major clinical problems. Evidence indicates that COX2/ PGE2/EP axis has a critical role in tumorogenesis and chemoresistance. This study assessed the relation of the COX-2 gene expression with chemoresistance in colon cancer (CC) patients. Also, it explored the effect of chemotherapy on COX-2 expression. The study included 24 patients with CC without chemotherapeutic treatment and 24 chemoresistant CC patients. Tumor and adjacent non-neoplastic colon tissue samples were collected and COX-2 mRNA expression was measured. Also, COX-2 and its related genes; TROP2 and DUSP4 expression were analysed in 5 flurouracil andOxalliplatin treated Caco-2 and SW-620 cells. The results indicated significant upregulation of COX-2 expression in tissues of chemoresistant CC patients when compared with that inCC tissues without chemotherapy (p \u003C 0.001). There was a relation between COX-2 expression with lymph nodes, metastases and staging in both groups. Concerning in-vitro experiments, there was a dose dependent significant increase of COX-2, TROP2 and DUSP4 mRNA and protein expression levels in 5flurouracil andOxalliplatin treated cells. These findings demonstrated that overexpression of COX-2 in the chemoresistant CC patients. Both 5 flurouracil and Oxalliplatin induced COX-2 overexpression and in turn COX-2 upregulation may decrease the response of cancer to chemotherapy.  \nKeywords Colon cancer, COX-2, Chemoresistance, Chemotherapy  \nColorectal cancer (CRC) is the 3rd most common cancer and the 2nd major cause of cancer-related mortality worldwide, with about 900,000 mortalities annually1. Even after cancer resection, there was a relapse in 40–50% of cases who died due to metastasis, with an overall 5-year survival \u003C 60%2.  \nCellular proliferation has a crucial role in tumorigenesis and cyclooxygenase-2 (COX-2) enzyme regulates such process. It plays a role in various biological processes including cellular proliferation, angiogenesis, immunologic functions and inflammatory responses. These processes are vital for tumorogenesis (i.e. initiation and/or progression)3. COX-2 expression was predominantly localized in tumour cells, whereas some stromal cells, endothelial cells, and colonic normal mucosa adjacent to the cancer tissue stained weakly4,5.  \nCOX-2 overexpression has a role in many precancerous and cancerous lesions of epithelial origin, particularly in the GIT. A cancerous lesion with high COX-2 level showed more aggressiveness with a significant decrease in survival6. COX-2 overexpression may decrease cancer’s response to chemotherapy7. At the sametime chemotherapy may induce the expression of COX-28. Few studies evaluated the crosslink between COX-2, chemotherapy and chemoresistance.  \nChemotherapy is mainstay of cancer therapy. Along with debulking the malignant mass via killing tumor cells, chemotherapy also promotes tumor control through immunostimulation9. However, chemoresistance and tumor relapse are still significant issues, suggesting that the chemotherapy-immunostimulation is usually not potent, not durable and/or overcome by immune evasion10.  \nRecent report confirmed that cancer cell-intrinsic activation of COX-2 / PGE2 pathway post-chemotherapy altered the inflammatory signaling pathways of treated malignant cells. Furthermore, COX-2 overexpression postchemotherapy impaired the efficacy of PD-1 inhibitors and chemotherapy combinations11. Previous studies had implicated PGE2; the major product of COX-2; produced by dying tumor cells postchemotherapy in stimulating the proliferation of tumour cells and tumour repopulation12, 13.  \nWe hypothesized chemotherapy could upregulate COX-2 in colon cancer (CC) cells and in turn COX-2 upregulation limits","cbCaimsGYoWqmbsA","https://ap.wps.com/l/cbCaimsGYoWqmbsA","pdf",1687937,"English","# Subjects and methods\n## Sample collection\n## Cell culture","[{\"question\":\"What was the main aim of this study in colon cancer?\",\"answer\":\"To assess the relationship between COX-2 gene expression and chemoresistance in colon cancer patients, and to explore how chemotherapy affects COX-2 expression.\"},{\"question\":\"How were patient samples collected and analyzed?\",\"answer\":\"Tumor and adjacent non-neoplastic colon tissue samples were collected from 48 cases and subjected to histopathologic examination, with COX-2 mRNA expression measured after snap-freezing and storage.\"},{\"question\":\"What did in-vitro treatment with 5-fluorouracil and oxaliplatin show?\",\"answer\":\"Dose-dependent increases in COX-2, TROP2, and DUSP4 mRNA and protein levels were observed in treated Caco-2 and SW-620 cells.\"}]","The interplay between COX-2, chemotherapeutic drugs, and chemoresistance in colon cancer - Original research | PDF",1790160843,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03e21a4b59c4ca82e2ba6719c7ba4c77.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f0a79a20b3512733ff578b42290eca9.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dbdf69bcdcf584fcb61657cda8623c2.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d16ca9d8366c5f12835a2f7c5991c52.webp",980,1287]